Skip to main content

U.S. flag An official website of the United States government

Animal and Plant Health Inspection Service
U.S. Department of Agriculture

CURRENT CVB Notices

Last Modified: Jan 8, 2021
Print
Year of Publication
2021   2020   
2019   2018   2017   2016   2015   2014   2013   2012   2011   2010   
2009   2008   2007   2006   2005   2004   2003   2002   2001   1999
CVB Notices - 2021
ID Title
21-01 Issuance of Licenses
21-02 Record Audit Inspections
Back to Top
CVB Notices - 2020
ID Title
87 Veterinary Biological Products in Licensed Establishments Produced and Destroyed 01/01/2019 through 12/31/2019
20-01 Issuance of Licenses
20-02 NCAH Portal Functionality: Electronic Labeling Submission Revision
20-03 Issuance of Licenses
20-04 Issuance of Licenses
20-05 Name Change for Biologicals containing Glaesserella parasuis, formerly Haemophilus parasuis, and Clostridioides difficile, formerly Clostridium difficile
20-06 Virtual Inspections for Remodeled or New Facilities for Existing Licensed Establishments
20-07 Issuance of a Conditional License for Epizootic Bovine Abortion Agent Vaccine, Live Culture
20-08 Update to Equine Parvovirus Extraneous Agent Testing Requirement for Equine-Origin Antibody, Antitoxin, Antivenin, Serum, and Plasma Biological Products Regulated by APHIS
20-09 Issuance of Licenses
20-10 Certification of Veterinary Vaccines and Immunotherapeutics as Containing Genetically Modified Organisms
20-11 Documenting Appropriate Details for Potency Tests
20-12 Veterinary Vaccines Targeting SARS-CoV-2 Virus in Mink
20-13 Use of Nonproprietary Names from the United States Adopted Names (USAN) Council as True Names for Veterinary Biologic Immunotherapeutics
Back to Top
CVB Notices - 2019
ID Title
86 Veterinary Biological Products in Licensed Establishments Produced and Destroyed 01/01/2018 through 12/31/2018
19-01 Issuance of Licenses
19-02 Issuance of Licenses
19-03 New Extraneous Agent Testing Requirement for Equine-Origin Antibody, Antitoxin, Serum, and Plasma Products Regulated by APHIS
19-04 Name Change for Biologicals Containing Mycobacterium avium subspecies paratuberculosis, formerly Mycobacterium paratuberculosis
19-05 Name Change for In Vitro Diagnostics (Test Kits) Intended to Detect Canine or Feline Heartworm Antigen
19-06 Issuance of Licenses
19-07 Discontinued Availability of Pasteurella multocida 169 (Porcine) Bacterin
19-09 Availability of Newcastle Disease Isolate and Sequence Information
19-10 Expanded NCAH Portal Functionality: APHIS Form 2005 Applications for Sale and Distribution
19-11 Expanded NCAH Portal Functionality: APHIS Form 2005 Applications for Research and Evaluation, and Transit Shipment Permits
19-12 Issuance of a Conditional License for Avian Reovirus Vaccine, Killed Virus
19-13 Issuance of Licenses
19-14 Extension of Implementation Period of Single Tier Label Claim
19-15 Availability of New Inactivated Veterinary Rabies Reference
Back to Top
CVB Notices - 2018
ID Title
85 Veterinary Biological Products in Licensed Establishments Produced and Destroyed 01/01/2017 through 12/31/2017
18-01 Issuance of Licenses
18-02 Issuance of a Conditional License for Avian Paramyxovirus Vaccine, Type 1, Killed Virus
18-03 Changes in True Names Based on Accepted Nomenclature
18-04 Expanded NCAH Portal Functionality: Submission of Export Documents
18-05 Detection of Senecavirus A in Veterinary Biological Products
18-06 Issuance of Licenses
18-07 Digital Signatures on Microsoft Word Documents
18-08 Expanded NCAH Portal Functionality: Submission of Facility Documents
18-09 Implementation Period for the Submission of Adverse Event Reports
18-10 Issuance of Licenses
18-11 Policy for Long-Term Recognition of CVB Digital Signatures in Microsoft Word documents
18-12 Issuance of Licenses
18-13 Labeling of Vaccines Containing Porcine Circovirus Type 2
Back to Top
CVB Notices - 2017
ID Title
84 Veterinary Biological Products in Licensed Establishments Produced and Destroyed 01/01/2016 through 12/31/2016
17-01 Issuance of Licenses
17-02 Issuance of a Conditional License for Moraxella Bovoculi Bacterin
17-03 Expanded NCAH Portal Functionality: Electronic Outlines of Production and Special Outlines
17-04 Availability of Avian Influenza Isolate and Sequence Information
17-05 Issuance of Licenses
17-06 Option to Remove Back-titration Hamsters from In Vivo Potency Tests for Leptospira Serogroups Pomona and Grippotyphosa
17-07 Transfer of Availability of Cell Lines from the Center for Veterinary Biologics
17-08 Retention of Policy Documents Posted to Center for Veterinary Biologics Website
17-09 Issuance of Licenses
17-10 Discontinued Availability of Diagnostic Test Kit Serial Release Panels Obtained from the Center for Veterinary Biologics (CVB)
17-11 Facility Documents Processing Changes – Pilot Project
Draft of the FDS and instructions for use
17-12 Issuance of Licenses
17-13 Revised Scope of Eligibility for Studies Requiring Single-Tier Summaries
17-14 Relative Potency Terminology for References and Related Preparations
17-15 Center for Veterinary Biologics Laboratory-supplied Reagents
17-16 Issuance of a Conditional License for Canine Osteosarcoma Vaccine, Live Listeria Vector
Back to Top
CVB Notices - 2016
ID Title
16-02 Availability of Avian Influenza Isolate and Sequence Information
16-03 Veterinary Biologics Containing Senecavirus A
16-05 Initiation of the National Centers for Animal Health (NCAH) Portal for the Center for Veterinary Biologics
16-07 In-depth Inspection Report Format
16-12 Name Change for Biologicals Containing Haemophilus paragallinarum, Babesia equi, and Ehrlichia risticii
16-13 Cancellation of Veterinary Services Memorandum 800.90 and 800.92
16-14 Expansion of the National Centers for Animal Health (NCAH) Portal for the Center for Veterinary Biologics
16-15 Implementation of Single Label Claim and Labeling/Packaging Rules
16-16 Issuance of Licenses
Back to Top
CVB Notices - 2015
ID Title
15-03 Adjustment for Clostridium perfringens Type C and Type D Reagents
15-04 Nomenclature and Level of Identification Required for Leptospira Master Seed Bacteria and Challenge Cultures
15-06 Availability of Canine Influenza Virus Subtype H3N2
15-07 Availability of Avian Influenza Isolates
15-08 Changes to the Administrative Inspection Review Program
15-13 Option to Remove Back-titration Hamsters from In Vivo Potency Tests for Leptospira Serogroups Canicola and Icterohaemorrhagiae
Back to Top
CVB Notices - 2014
ID Title
14-06 Safety Data to Support Using Multiple Strains of Potentially Immunosuppressive Viruses in the Same Modified Live Product
14-10 Change in Distribution Policy for Memoranda and Notices
14-16 Processing Special Outlines Describing Proposed Serial Release Assays
Back to Top
CVB Notices - 2013
ID Title
13-02 Quarterly Acknowledgement Summaries for Selected Submissions
13-05 Use of Polymerase Chain Reaction (PCR) Assays to Measure Potency of Inactivated Protein-Based Biologicals
13-06 Reporting Inactivation Test Results on APHIS Forms 2008 for Inactivated Veterinary Biological Products with the Restriction "For Further Manufacture (FFM)"
13-10 Changes to the Rabies Virus NIH Potency Test Validity Requirements
13-17 Summary of Changes for Related Study Protocols
13-18 Discontinuing the Use of RelPot Software
Back to Top
CVB Notices - 2012
ID Title
12-03 Exemption to Shipping a Sample of Inactivated Lot or Bulk Rabies Antigen to the Center for Veterinary Biologics
12-04 Appropriate Use of Controls for Chicken Anemia Virus Extraneous Agent Testing, Availability of a PCR-based Testing Protocol, and Availability of a New Testing Reagent (Referenced Documents: VIRPRO0118 and VIRNPP0001)
12-05 Testing Exemptions for Antibody Product Donor Animals
12-06 Detection of Mycoplasma Contamination in Vaccines and Biological Products
12-07 Submission of Master Seeds, Master Cell Stocks, and Master Sequences to the Center for Veterinary Biologics for Confirmatory Testing
12-09 Licensing of Vaccines as Preharvest Food Safety Interventions
12-11 Virulent Systemic Feline Calicivirus Label Claims
12-12 Use of Humane Endpoints and Methods in Animal Testing of Biological Products
12-17 not issued
12-21 Conducting Dilution of Preservative Studies for Live Bacterial Vaccines
12-25 New Policy on Biological Product Samples Submitted to the Center for Veterinary Biologics and Concurrent Testing Selection Period
Back to Top
CVB Notices - 2011
ID Title
11-01 The Management and Disposition of Eggs, Chickens, and Biological Products Following a Chicken Anemia Virus (CAV) Outbreak in a Source Flock
11-02 Generation and Implementation of Draft Guidance
11-12 Product Licensing Plans
11-14 superseded by CVB Notice 15-02
11-18 Virus Inactivation and Safety Test for Rabies Virus Bulks, Title 9, Code of Federal Regulations (9 CFR), Part 113.209
Back to Top
CVB Notices - 2010
ID Title
10-10 Follow-up Sterility Check Testing
10-11 Obtaining the Testing Plan for Authorized Master Seed/Master Cell Sample Submissions
Back to Top
CVB Notices - 2009
ID Title
09-02 Dilution of Preservative Screening for Broth-Based Sterility Tests
09-04 Conversion Formulas for S/P Ratio to Titer in Diagnostic Test Kit Inserts
09-05 Consistency of Avian Safety Testing Parameters in Outlines of Production for Multi-fraction Avian Products
09-15 Autogenous Vaccines Containing Porcine Circovirus
09-25 Dilution of Preservative Screening for Plate-Based Sterility Tests
Back to Top
CVB Notices - 2008
ID Title
08-19 Electronic Maintenance of Paper Records
Back to Top
CVB Notices - 2007
ID Title
07-04 Submission of Outsourced Studies
07-06 Preparation and Testing of Experimental Biological Products that are Derived from Biotechnology
07-07 Post-Challenge Observation Periods for Efficacy Studies
Back to Top
CVB Notices - 2006
ID Title
06-03 Potential Contamination of Porcine Kidney Cells
06-06 Type (Species) Designation of Vaccines Containing Bovine Viral Diarrhea Virus(es)
06-11 Replacement of Potency Assay Reference Samples for Immunodiagnostic Test Kits
06-24 Exemptions to allow live poultry vaccines administered via wing web to be tested for detection of extraneous viable bacteria and fungi via Title 9, Code of Federal Regulations, Part 113.27 (e)
Back to Top
CVB Notices - 2005
ID Title
05-06 Requirements for Addition of Leptospira bratislava in Canine Bacterins
05-07 Biologics for Reduction of Colonization and/or Shedding in Animals
05-16 Posting of Selected Center for Veterinary Biologics Notices and Veterinary Services Memoranda on the Center for Veterinary Biologics Web Site for Comment
05-23 Chimera as an Additional Naming Convention for Live Recombinant Products
Back to Top
CVB Notices - 2004
ID Title
04-13 Use of Minimum Age Animals in Licensure Studies
04-16 Efficacy Requirements and Label Claims for Bovine Rotavirus Vaccine
04-17 Exemption to 3-year Master Seed Immunogenicity Retesting
Back to Top
CVB Notices - 2003
ID Title
03-08 Purpose of the Equine Infectious Anemia Weak Positive Serum Sample Outlined in Veterinary Services Memorandum No. 555-16
03-13 Detection of Avian Lymphoid Leukosis Virus in Veterinary Biological Products
03-14 Customer Feedback on Reagents
Back to Top
CVB Notices - 2002
ID Title
02-01 Critical Study Dates for Licensing and Reference Qualification Studies
02-15 Permit Requirements for Pathogenic Organisms, Including Challenge Materials
02-21 Domestic Manufacture of Biologicals Used in the Prevention or Treatment of Foreign Animal Diseases
02-24 Guidance Document for Veterinary Biologics Derived from Bioengineered Plants
02-25 Conditional Licenses for Products Containing Clostridium perfringens Type A
02-29 Availability of Monoclonal Antibodies from the Center for Veterinary Biologics
Back to Top
CVB Notices - 2001
ID Title
01-07 Identification of Testing Methods for Detection of Extraneous Agents in Fetal Bovine Serum
01-11 International Cooperation on Harmonization of Technical Requirements for the Registration of Veterinary Medicinal Products (VICH): Final Guidelines for Good Clinical Practice
01-16 Autogenous Products for Avian Influenza
Back to Top
CVB Notices - 1999
ID Title
99-19 Autogenous Virus Vaccines for Infectious Salmon Anemia Virus
Back to Top
Complementary Content
${loading}